Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

Bayer Now Enrolling Patients for Global Pulmonary Arterial Hypertension Study
News | Hypertension | July 05, 2017
July 5, 2017 — Bayer has enrolled the first patient in a global Phase IV study assessing the clinical effects of...
FDA Grants Priority Review of Xarelto sNDA for 10 mg Dose
News | Antiplatelet and Anticoagulation Therapies | June 29, 2017
June 29, 2017 — Janssen Research & Development LLC announced the U.S. Food and Drug Administration (FDA) accepted...
radial access, transradial access trial using anticoagulants
News | Radial Access | June 15, 2017
June 15, 2017 — In patients undergoing transradial primary percutaneous coronary intervention (PCI) for ST-elevation...
Cost comparison between NOACs, novel oral anticoagulants
News | Antiplatelet and Anticoagulation Therapies | May 31, 2017
May 31, 2017 – The results from the first real-world, matched head-to-head study comparing all-cause healthcare costs...
Data was positive from the Watchman Left Atrial Appendage Closure (LAAC) Device from the EWOLUTION registry
News | Atrial Fibrillation | May 30, 2017
May 30, 2017 — Data was positive for safety and efficacy rates of the Watchman Left Atrial Appendage Closure (LAAC)...
Statins Associated With Improved Heart Structure and Function
News | Pharmaceuticals | May 26, 2017
May 26, 2017 — Statins are associated with improved heart structure and function, according to research presented at...
Feature | Pharmaceuticals | May 16, 2017
May 16, 2017 – Results of a groundbreaking clinical trial demonstrate the effectiveness of a novel, fast-acting nasal...
Analysis Shows Increased Risk of Early Stroke with New-Onset Atrial Fibrillation Post-TAVR, SCAI 2017 late-breaking clinical trial
News | Stroke | May 12, 2017
May 12, 2017 — More than one-third of patients undergoing transcatheter aortic valve replacement (TAVR) were observed...
anticoagulants increase dementia risks
Feature | Antiplatelet and Anticoagulation Therapies | May 12, 2017
May 12, 2017 – A new study found that dementia rates increase with delays in starting anticoagulation treatment for...
Siemens Xprecia Stride anticoagulation, coagulation PT/INR or INR testing at the point of care (POC)

Point-of-care coagulation PT/INR testing with handheld devices can help improve outcomes with more convenient and frequent measurements to keep patients within the therapeutic range of anticoagulant agents.

Feature | Point of Care Testing | May 05, 2017 | Nicholas C. Vanderslice, Ph.D., and Arnol S. Rios
Point-of-care (POC) coagulation analyzers that measure prothrombin time/international normalized ratio (PT/INR) on...
Prescribing Patterns Change Following Direct Marketing Restrictions
News | Pharmaceuticals | May 05, 2017
May 5, 2017 — A study of how policies restricting pharmaceutical promotion to physicians affect medication prescribing...
An electrophysiology EP ablation procedure to treat a heart arrhythmia
Feature | HRS | May 16, 2017
May 16, 2017 — Here is a list of the late-breaking clinical trials presented at the Heart Rhythm Society (HRS) 2017...
EBBINGHAUS study, evolocumab, repatha, statin therapy, cognitive issues, ACC.17 study
News | Pharmaceuticals | April 03, 2017
April 3, 2017 — There is no evidence that adding a new cholesterol-lowering drug to treatment with a statin causes...
Ablation procedure, EP lab, Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation
Feature | Atrial Fibrillation | March 29, 2017
March 29, 2017 — Uninterrupted treatment with dabigatran (Pradaxa), a non-vitamin K, novel antagonist oral...
synthetic HDL-C injection, cholesterol, arterial plaque, heart attack patients, CARAT trial, ACC.17, clinical study
News | Pharmaceuticals | March 29, 2017
March 29, 2017 — Injection of a novel form of synthetic high-density lipoprotein cholesterol (HDL-C), or good...